{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Imaging of Novel Oncologic Treatments in Lung Cancer Part 1: Systemic Therapies

Activity Steps

Description

Method of Participation in the Learning Process/Evaluation Method

Successful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.

Getting the Most out of the Activity

As you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.

While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Assess the clinical background of targeted medical therapies in lung cancer.
  2. Outline the novel patterns of treatment response observed in patients receiving targeted cancer therapies and why conventional response assessment tools such as RECIST 1.1 may not be applicable in these patients.
  3. Analyze imaging finding of thoracic-related adverse events associated with targeted medical therapies.
Price: FREE

Credits:

  • ACCME 1.5 CME
  • ABR 1.5 CME (SAM)

Lippincott Continuing Medical Education Institute, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Lippincott Continuing Medical Education Institute, Inc. designates this enduring material for a maximum of 1.5 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This module meets the American Board of Radiology's (ABR) criteria for self-assessment toward the purpose of fulfilling requirements in the ABR Maintenance of Certification (MOC) program.

Professions: Physician
Test Code: JTI0120A
Published: Janaury 2020
Expires: 12/31/2021
Required Passing Score: 4/5 (80%)
Authors: Darragh Halpenny, MB, BCh, BAO, Elisabeth O'Dwyer, MB, BCh BAO, Jeffrey Girshman, MD, and Michelle S. Ginsberg, MD
Categories: Cancer , Oncology , Pulmonary , Thoracic
Specialties: Oncology, Pulmonary, Radiology